News Article

He liked the company so much when he was CEO, he came back and bought it!

The latest interview in our “Candesic in conversation with” series is with the multi-talented Tony Veverka from Y1 Capital. Having enjoyed a distinguished career at the likes of Bupa, Ultralase, and Transform Healthcare, he has changed track recently and joined the ranks of investors.

Click below to read our exclusive interview.

Candesic has advised numerous leading corporates and investors in the ophthalmology and orthopaedics sector on strategic matters and market assessments. If you would like to know more about the services Candesic offers, email [email protected] or call +44 (0)20 7096 7680.